This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Arthur J. Gallagher Q2 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
AJG's Q2 revenue climbs 16% on strong fee and finance income, but EPS slips short of expectations.
Aflac Gears Up for Q2 Earnings: Ready to Quack or Set to Crack?
by Zacks Equity Research
AFL braces for Q2 results with EPS likely to decline 6.6% and revenue off 13.7% as U.S. and Japan earnings face pressure.
Is the Options Market Predicting a Spike in Marsh & McLennan Companies Stock?
by Zacks Equity Research
Investors need to pay close attention to Marsh & McLennan Companies stock based on the movements in the options market lately.
Willis Towers Q2 Earnings & Revenues Beat Estimates on Lower Costs
by Zacks Equity Research
WTW Q2 results reflect strong revenue contribution from the Risk & Broking segment, as well as expanded EBITDA margin and lower expenses.
Allstate to Report Q2 Earnings: Can Auto Brand Strength Save the Day?
by Zacks Equity Research
ALL's Q2 earnings are likely to witness rising auto underwriting income and premium gains, facing cost headwinds.
AJG Picks Equinox to Expand Health Benefit Services in Pennsylvania
by Zacks Equity Research
Arthur J. Gallagher strengthens its presence in Pennsylvania through the Equinox acquisition, enhancing its reach in health benefits consulting.
Marsh & McLennan Q2 Earnings Beat on Risk and Insurance Strength
by Zacks Equity Research
MMC posts strong Q2 with EPS up 11% and revenues up 12%, fueled by robust growth in Risk and Insurance Services.
Marsh & McLennan (MMC) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Marsh & McLennan (MMC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Marsh & McLennan Q2 Preview: Will Cost Pressures Weigh on Results?
by Zacks Equity Research
MMC's Q2 results are likely to reflect growth in Risk and Insurance Services and Consulting, but rising costs could weigh on margins.
BRO Outperforms Industry, Trades at Premium: How to Play the Stock
by Zacks Equity Research
Brown & Brown stock remains poised to gain from new business, solid retention, higher core commissions and fees, strategic buyouts and prudent capital deployment.
Unveiling Marsh & McLennan (MMC) Q2 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Marsh & McLennan (MMC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Marsh & McLennan Boosts Dividend by 10% to 90 Cents Per Share
by Zacks Equity Research
MMC hikes its quarterly dividend by 10% to 90 cents per share, marking its 16th straight year of increases and sustaining its active record of returning capital to shareholders.
Marsh & McLennan (MMC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Marsh & McLennan (MMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WTW Outperforms Industry, Trades at a Discount: How to Play the Stock
by Zacks Equity Research
Willis Towers stock rallies on the back of a strong new business, strategic acquisitions, solid customer retention levels and financial flexibility.
Marsh & McLennan Expands in Florida With Excel Insurance Acquisition
by Zacks Equity Research
MMC expands in South Florida with MMA's acquisition of Excel Insurance, boosting auto and marine coverage capabilities.
Marsh & McLennan to Acquire Validate Health to Expand Healthcare Reach
by Zacks Equity Research
MMC's Oliver Wyman to acquire Validate Health, boosting analytics capabilities for value-based healthcare growth.
Zacks Industry Outlook Highlights Brown and Brown, Marsh & McLennan, Arthur J. Gallagher and Willis Towers Watson Public
by Zacks Equity Research
Despite near-term headwinds, BRO, MMC, AJG, and WTW show resilience through M&A and tech-led growth.
4 Stocks to Watch From the Prospering Insurance Brokerage Industry
by Sushmita Sarker
The increased demand for insurance products, strategic acquisitions and the adoption of technology should drive the performance of Zacks Insurance Brokerage industry players like ERIE, BRO, MMC, AJG and WTW.
Hims & Hers Health and Sociedad Quimica y Minera de Chile have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
HWM surges on aerospace demand, rising earnings, and upgraded guidance, while SQM stumbles on weak results and estimate cuts.
Goldman Gaining Ground in Japan: What's Fueling the Momentum?
by Zacks Equity Research
GS eyes growth in Japan's OCIO market as it pursues growth in asset management and tailored investment solutions.
BRO Lags Industry, Trades at Premium: What Should Investors Do Now?
by Zacks Equity Research
Brown & Brown stock remains poised to gain from new business, solid retention, higher core commissions and fees, strategic buyouts and prudent capital deployment.
AJG Outperforms Industry, Trades at Premium: How to Play the Stock
by Zacks Equity Research
Arthur J. Gallagher stock gains on the back of strategic acquisitions, solid retention and improving renewal premiums, as well as financial flexibility.
Brown & Brown (BRO) Up 3.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Brown & Brown (BRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
WTW Rises 24.7% in a Year but Lags Industry: How to Play the Stock
by Zacks Equity Research
Willis Towers stock rallies on the back of a strong new business, strategic acquisitions, solid customer retention levels and financial flexibility.
Reasons Why Investors Should Hold on to Marsh & McLennan Shares Now
by Zacks Equity Research
MMC has maintained consistent cash flow generation for several years, supporting its disciplined capital distribution.